NCT02597829View on ClinicalTrials.gov

Does Clinical Response Correlate With Serum Certolizumab Levels?

PHASE4UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

October 31, 2018

Conditions

Crohn's Disease

Interventions

DRUG

Certolizumab Pegol

Subcutaneous Injection

Trial Locations (1)

32789

Shafran Gastroenterology Center, Winter Park

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

UCB Pharma

INDUSTRY

lead

Shafran Gastroenterology Center

OTHER